FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

The FDA approved a supplemental application for QNASL (beclomethasone dipropionate) submitted by Teva Respiratory, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• QNASL (beclomethasone dipropionate)

Snippet

SUPPL AP for QNASL (BECLOMETHASONE DIPROPIONATE)